NCCN Guidelines® Updates: Breast Cancer - New Approaches to Endocrine Therapy

This information was originally presented at the NCCN 22nd Annual Conference: Improving the Quality, Effectiveness, and Efficiency of Cancer Care™ held in Orlando, Florida, from March 23 - 25, 2017.

NCCN Guidelines® Updates: Breast Cancer - Use of Biomarkers and Multigene Assays

This information was originally presented at the NCCN 22nd Annual Conference: Improving the Quality, Effectiveness, and Efficiency of Cancer Care™ held in Orlando, Florida, from March 23 - 25, 2017.

NCCN Guidelines® Updates: Breast Cancer - Evolving Radiation Therapy Recommendations

This information was originally presented at the NCCN 22nd Annual Conference: Improving the Quality, Effectiveness, and Efficiency of Cancer Care™ held in Orlando, Florida, from March 23 - 25, 2017.

Multi-Gene Testing for Hereditary Cancer: When, Why, and How?

This information was originally presented at the NCCN 22nd Annual Conference: Improving the Quality, Effectiveness, and Efficiency of Cancer Care™ held in Orlando, Florida, from March 23 - 25, 2017.

Recorded Presentation from the NCCN 2017 Congress Webinar Series: Breast Cancer - Late Stage Breast Cancer, Including SABCS Updates

Breast cancer is the most common malignancy in women in the United States and is second only to lung cancer as a cause of cancer death. The treatment of breast cancer is rapidly evolving.

Recorded Presentation from the NCCN 2017 Congress Webinar Series: Breast Cancer - Breast Cancer Risk Reduction Strategies

Breast cancer is the most common malignancy in women in the United States and is second only to lung cancer as a cause of cancer death. The treatment of breast cancer is rapidly evolving.

Recorded Presentation from the NCCN 2017 Congress Webinar Series: Breast Cancer - Adjuvant and Neoadjuvant Therapies, Including SABCS Updates

Breast cancer is the most common malignancy in women in the United States and is second only to lung cancer as a cause of cancer death. The treatment of breast cancer is rapidly evolving.

Recorded Presentation from the NCCN 2017 Congress Webinar Series: Breast Cancer - Imaging Studies in Breast Cancer

Breast cancer is the most common malignancy in women in the United States and is second only to lung cancer as a cause of cancer death. The treatment of breast cancer is rapidly evolving.

Recorded Presentation from the NCCN 2017 Congress Webinar Series: Breast Cancer - Role of Molecular Assays in the Management of Breast Cancer

Breast cancer is the most common malignancy in women in the United States and is second only to lung cancer as a cause of cancer death. The treatment of breast cancer is rapidly evolving.

Recorded Presentation from the NCCN 2017 Congress Webinar Series: Breast Cancer - Surgical Management of the Axilla in Early Stage Breast Cancer, Including SABCS Updates

Breast cancer is the most common malignancy in women in the United States and is second only to lung cancer as a cause of cancer death. The treatment of breast cancer is rapidly evolving.

Pages

Subscribe to RSS - Breast Cancer